Cancer researchers report positive results for larotrectinib, a ‘tumor-agnostic’ drug by Alan Boyle on March 30, 2018March 30, 2018 at 6:03 pm Two clinical studies have provided evidence suggesting that an experimental precision-medicine drug called larotrectinib can fight soft-tissue tumors regardless of the patient’s age or the type of tumor. Seattle Children’s… Read More